On 1 September 2026 Korea's Ministry of Trade, Industry and Resources reported August cosmetics exports of USD 1.312 billion, up 52.1% year on year. It was the largest August on record and the tenth consecutive month of growth. Cumulative exports for January through August reached USD 9.637 billion, against USD 7.346 billion a year earlier.
That is the number the trade press will quote for the next two weeks. It is not the number that changes anyone's plan. Buried in the same release is a regional breakdown for the first 25 days of the month, and in it the European Union takes USD 130 million against China's USD 120 million.
The ministry does not flag that as a milestone, and this piece will not claim it is the first time it has happened — earlier monthly releases do not consistently carry a China line, so the comparison cannot be run backwards with confidence. What can be said is narrower and still large: in the most recent data Korea publishes, Europe is now the bigger of the two, and it is growing twenty times faster.
What exactly did the August data show, and what did it not show?
The regional figures are worth stating precisely, because the precision is where the argument lives.
For 1–25 August, on a customs-clearance basis, the ministry reported the United States at USD 230 million (up 58.0%), the EU at USD 130 million (up 106.6%), China at USD 120 million (up 5.3%), and the CIS region at USD 60 million (up 25.9%). These are provisional partial-month figures. They are not the August total, and anyone quoting them as such is quoting them wrong.
Two further caveats belong in the same breath. First, the EU line is not the same as Europe, and the China line is not the same as Greater China. NH Investment & Securities, working from customs data on a narrower product basis, put August exports at USD 1.0816 billion and found that shipments to Greater China fell 6% while everything outside it rose 73%. On that view the seven largest European destinations reached a 14% share — level with Greater China, not past it. The honest sentence is that Europe has drawn even with Greater China and has passed mainland China. That is still the most consequential line in the release.
Second, the two totals do not agree. The ministry's USD 1.312 billion and NH's USD 1.0816 billion are different series built on different product classifications. Neither is wrong. A brand modelling its 2027 European allocation off one of them should know which one it is holding.
Why is Europe compounding at triple digits while China grows at five percent?
Part of the answer is arithmetic. Europe is growing from a small base and China is not, so the percentages are not comparable measures of effort.
But the destination-level detail is harder to dismiss as a base effect. Among Korea's top thirty export markets in August, the fastest-growing were the Czech Republic (up 492%), Estonia (up 399%), the Netherlands (up 374%) and the United Kingdom (up 233%). Those are not markets a Korean conglomerate opened with a distributor contract and a trade-show booth. The Czech Republic and Estonia in particular are marketplace-and-logistics outcomes. APR recorded its highest-ever Amazon sales across seven European markets in August.
What is growing in Europe is the indie cohort, arriving through cross-border e-commerce and regional marketplaces rather than through the incumbent perfumery channel. That has a direct consequence for how the category gets shelved when it finally goes offline.
Which door are Korean brands actually walking through in Europe?
In the United States, K-beauty's offline entry has run through curation partnerships at prestige and mass-prestige retail. Sephora began carrying an Olive Young-curated K-Beauty Edit on 20 August, roughly 150 products from 19 brands across about 580 US doors — Sephora's own release said more than 500, and the Korean press reported approximately 580. Ulta Beauty added five Korean brands in the second quarter alone. Target selected twelve K-beauty labels among the ninety brands in its Beauty Studio rollout across 600-plus stores. The framing in each case is discovery and curation, and the price architecture sits alongside Western prestige skincare.
Europe is being opened through a different tier. On 6 August, Superdrug launched Korean colour cosmetics across more than sixty UK stores — Etude, banila co., Missha, rom&nd, Fwee, plus a refreshed edit from the specialist retailer Pureseoul. In early September, Pureseoul went a tier lower again, launching an exclusive K-Beauty Mini Mart at Primark. Personal Care Insights reported the range across 22 stores in the UK and Northern Ireland; Primark has not published a door count, and the British trade press covering the launch did not carry one.
Two things about the Primark range matter more than its size. The assortment is exclusive to Primark and is not sold in Pureseoul's own stores. And almost every label in it is a diffusion brand rather than a parent brand.
Why are Korean companies inventing cheaper brands to sell in Europe?
The Primark line-up reads as follows: Dermablock by Cell Fusion C, The Essential by Ariul, First Edition by Sungboon Editor, CERABASE by Real Barrier (a Neopharm brand), Dropbe by The Saem, and Dear Thing by Milktouch. One outlet's account of the range also lists product from The Saem itself alongside its own sister label.
Every one of the six is a diffusion label created by an established Korean house for a price tier its parent brand cannot occupy. Pureseoul's chief executive, Leslie Tang, described the mechanism plainly: "In Korea, many of our brand partners are creating 'mini' or 'sister' brands to meet the growing demand for more accessible K-Beauty, and we saw an opportunity to curate this for the UK."
This is a deliberate piece of brand architecture, and it is being executed at speed. Cell Fusion C has been built since 2001; Real Barrier passed its tenth anniversary last year. A Korean company that has spent that long establishing a clinical, evidence-led proposition does not want the name discounted onto a Primark fixture. So it ships a second name instead, manufactured by the same ODM partners, formulated to a lower cost target, and sold with no visible line back to the parent.
The manoeuvre solves an immediate problem. Whether it solves the next one is less clear.
What does a value-first entry cost a brand that is premium somewhere else?
Price archaeology is trivially easy now. A shopper in Manchester who likes Dropbe can find The Saem in ninety seconds, and a buyer at a German perfumery evaluating Real Barrier can find CERABASE just as fast. Diffusion lines worked in an era when the two tiers lived in different physical spaces and different catalogues. They now live in the same search results.
There is also a sequencing problem specific to this market. The US entry established Korean skincare at a mid-to-prestige price point and is, on Ulta's own account of its second quarter, delivering strong double-digit growth there. The European entry is establishing the same category one tier down, in the same eighteen-month window, for many of the same manufacturing groups. Korea is building two incompatible price memories in two regions at once, and the internet does not respect the border between them.
Superdrug's own research points at where the opening actually is: 68% of its surveyed customers associate South Korea with skincare, but only 43% make that connection with colour cosmetics, rising to 56% among 18-to-24s. Colour is the unclaimed half of the European proposition, and colour is exactly what a value channel is good at selling — swatchable, low-consideration, repeat-purchase.
How should an operator read this?
Three readings are available, and they lead to different decisions:
- The channel reading. Europe's retail structure is genuinely different from America's — value and drugstore formats carry more of the beauty market — so entering through Primark and Superdrug is simply meeting the market where it is. On this view the sister brands are correct and permanent.
- The sequencing reading. Value retail is the fastest available route to physical distribution while prestige perfumery is still deciding, and the sister brands are a bridge to be retired once the parent brands secure Douglas, Sephora France or Marionnaud. On this view they are correct and temporary, and the retirement plan needs to exist now.
- The structural reading. The manufacturing base — Cosmax, Kolmar, Cosmecca and the indie ODM tier behind them — can produce a credible product at almost any price point, so Korean houses will keep launching names into whatever tier has open shelf space. On this view brand architecture is downstream of factory capacity, and the tiers will keep multiplying until something forces consolidation.
The first two are testable within a year. The third is the one that would change how a brand hires.
What to watch next
The September trade release, due in early October, will carry full-month regional figures rather than a 1–25 provisional. If the EU line clears China again on complete data, August was a threshold and not a rounding artefact.
The second thing to watch is quieter. Track whether Dermablock, Dropbe and CERABASE acquire their own European retail listings independently of Pureseoul over the next two seasons. If they do, Korea has not built diffusion lines. It has built six new brands, and the parents have permanently ceded the value tier to companies they own but no longer control the positioning of.
